Sebaceous Differentiation in Squamous Cell Carcinoma of the Larynx and Adjacent Pharynx: Case Report with Review and Discussion of the Literature
Among the variants of squamous cell carcinoma (SCC) of the head and neck arising in mucosal surfaces, examples with sebaceous differentiation are exceedingly rare. We present a new case of SCC with sebaceous differentiation, developing in the larynx of a 64 year-old male, cigarette smoker and alcohol drinker. The tumor extended transglottically, metastasized to cervical lymph nodes, and killed the patient after 12 months. Comparing this case with four previously reported cases of SCC with sebaceous differentiation, two arising in the larynx and the other two in the adjacent pharynx, all five patients mostly shared the following features: appearance of the tumor in the seventh decade of life, heavy tobacco smoking, alcohol intake in three, surgery as mainstay treatment, tumor size between 2 and 4.7 cm, and regional lymph node metastases in four of them. Out of the four patients with a follow up of 12 months, two died of disease, one was alive with disease, and only one was alive without disease. One patient was lost for follow up. In conclusion, mucosal SCC with sebaceous differentiation is a very rare variant of SCC that when arising in the larynx and anatomically adjacent parts of the pharynx behaves aggressively and bears a dismal prognosis. The recognition of new cases of this entity requires special awareness of its phenotypic features and may be important for further assessment of its behavior.
KeywordsLarynx and adjacent pharynx Squamous cell carcinoma variants Sebaceous differentiation Prognosis
Compliance with Ethical Standards
Conflict of interest
All authors declare that they do not have any conflict of interests.
Research Involving Human or Animal Participants
This article does not contain any studies with human participants or animals performed by any of the authors.
- 2.Font RL, Croxatto JO, Rao NA. Atlas of tumor pathology. Tumors of the eye and ocular adnexa, 4th series, fascile 5. Washington, D.C.: Armed Forces Institute of Pathology; 2006. p. 15, 33, 183–191.Google Scholar
- 3.Ellis GL, Auclair PL. Atlas of tumor pathology. Tumors of the salivary glands, 4th series, fascicle 9. Washington, D.C.: Armed Forces Institute of Pathology; 2008. p. 377–380.Google Scholar
- 4.Gnepp DR. Sebaceous carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. WHO classification of head neck tumors. Lyon: IARC Press; 2005. p. 231.Google Scholar
- 5.Gnepp DR, Assaad A, Ro JY. Sebaceous adenocarcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head neck tumors. Lyon: IARC Press; 2017. p. 178–179.Google Scholar
- 14.Miyamoto K, Yamagawa T, Azuma M, et al. Establishment of a transformed human epithelial cell line with a sebaceous phenotype and effect of epidermal growth factor and dibutyryl cyclic adenosine 3′-5′ monophosphate on the cellular phenotype. Cancer J. 1989;3:414–22.Google Scholar
- 15.Hellquist H, Skalova A. Sebaceous carcinoma and sebaceous lymphadenocarcinoma. In: Hellquist H, Skalova A, editors. Histopathology of the salivary glands. Berlin: Springer; 2014. p. 407–409.Google Scholar